Global Cord Blood Corporation (CORBF)

Market Cap	167.39M
Revenue (ttm)	196.10M
Net Income (ttm)	79.03M
Shares Out	133.91M
EPS (ttm)	0.65
PE Ratio	1.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,125
Open	1.750
Previous Close	1.750
Day's Range	1.250 - 1.750
52-Week Range	0.850 - 2.000
Beta	-0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: Ting Zheng
• Employees: 1,202
• Stock Exchange: OTCMKTS
• Ticker Symbol: CORBF

Financial Performance

In 2021, Global Cord Blood's revenue was 1.24 billion, an increase of 7.21% compared to the previous year's 1.16 billion. Earnings were 501.07 million, a decrease of -1.41%.

Financial numbers in CNY